These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Chlorpropamide hepatotoxicity: report of a case and review of the literature. Schneider HL; Hornbach KD; Kniaz JL; Efrusy ME Am J Gastroenterol; 1984 Sep; 79(9):721-4. PubMed ID: 6475904 [TBL] [Abstract][Full Text] [Related]
12. Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus. Seaman WE; Ishak KG; Plotz PH Ann Intern Med; 1974 Jan; 80(1):1-8. PubMed ID: 4810348 [No Abstract] [Full Text] [Related]
15. [Diagnosis of drug-induced hepatitis]. Polunina TE Ter Arkh; 1988; 60(2):119-21. PubMed ID: 3368853 [No Abstract] [Full Text] [Related]
16. The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes. Tuccori M; Wu JW; Yin H; Majdan A; Azoulay L Diabetes Care; 2015 Nov; 38(11):2083-9. PubMed ID: 26341130 [TBL] [Abstract][Full Text] [Related]
17. Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: a nested case-control study. Abdelmoneim AS; Eurich DT; Gamble JM; Johnson JA; Seubert JM; Qiu W; Simpson SH Diabetes Obes Metab; 2014 Jan; 16(1):22-9. PubMed ID: 23802997 [TBL] [Abstract][Full Text] [Related]